✦ LIBER ✦

Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework

Book ID: 111726884
Publisher: Nature Publishing Group
Year: 2001
Tongue: English
Weight: 105 KB
Volume: 69
Category: Article
ISSN: 0009-9236
DOI: 10.1067/mcp.2001.113989

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Biomarkers and surrogate endpoints

✍ J. K. Aronson 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Biomarkers and surrogate endpoints in cl

Biomarkers and surrogate endpoints in clinical trials

✍ Thomas R. Fleming; John H. Powers 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 492 KB

Comparing Biomarkers as Principal Surrog

Comparing Biomarkers as Principal Surrogate Endpoints

✍ Ying Huang; Peter B. Gilbert 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB

Conceptual framework and definition

📂 Article 📅 2009 🏛 John Wiley and Sons ⚖ 251 KB

Intraepithelial neoplasia, surrogate end

Intraepithelial neoplasia, surrogate endpoint biomarkers, and cancer chemoprevention

✍ Dr. Charles W. Boone; Gary J. Kelloff 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 930 KB

Neoplasia is a progression of molecular, cellular, and tissue changes starting with a critical cell mutation and advancing by clonal evolution, involving further multiple mutations and expanding mutated clones. This process is characterized by five general stages: latency, focal growth of normal-app

Cervical cancer chemoprevention, vaccine

Cervical cancer chemoprevention, vaccines, and surrogate endpoint biomarkers

✍ Michele Follen; Frank L. Meyskens Jr.; Ronald D. Alvarez; Joan L. Walker; Maria 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 883 KB

At the Second International Conference on Cervical Cancer, held April 11-14, 2002, experts in cervical cancer prevention, detection, and treatment reviewed the need for more research in chemoprevention, including prophylactic and therapeutic vaccines, immunomodulators, peptides, and surrogate endpoi